Partner Therapeutics has appointed Colleen Mockbee to serve as chief development officer. Mockbee comes to Boston-based Partner from Eli Lilly (NYSE: [[ticker:LLY]]), where she spent 20 years working in various drug development positions. Partner emerged from stealth in early February with $60 million in funding and an immune system-boosting drug it acquired from Sanofi (NYSE: [[ticker:SNY]]).
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
